Clicky

Vincera Pharma, Inc.(VINC)

Description: Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.


Keywords: Medicine Cancer Biopharmaceutical Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology

Home Page: vincerx.com

VINC Technical Analysis

260 Sheridan Avenue
Palo Alto, CA 94306
United States
Phone: 650 800 6676


Officers

Name Title
Dr. Ahmed M. Hamdy M.D. Founder, Chairman & CEO
Mr. Tom C. Thomas J.D. Founder, Gen. Counsel & Chief Legal Officer
Dr. Raquel E. Izumi Ph.D. Founder, Pres, COO, Sec. & Director
Dr. John C. Byrd M.D. Founder & Chairman of Scientific Advisory Board
Mr. Alexander A. Seelenberger M.B.A., MBA Chief Financial Officer
Dr. Hans-Georg Lerchen Ph.D. Chief Scientific Officer
Ms. Melissa Merrick SPHR Sr. Director of People & Culture
Dr. David Nganele M.B.A., Ph.D. Head of Early Devel.
Dr. Beatrix Stelte-Ludwig Ph.D. Exec. Chief Devel. Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.2284
Price-to-Sales TTM: 0
IPO Date: 2020-05-27
Fiscal Year End: December
Full Time Employees: 56
Back to stocks